• No results found

VU Research Portal

N/A
N/A
Protected

Academic year: 2021

Share "VU Research Portal"

Copied!
7
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

VU Research Portal

Renal and Pulmonary Aspects of Birt-Hogg-Dubé syndrome

Johannesma, P.C.

2016

document version

Publisher's PDF, also known as Version of record

Link to publication in VU Research Portal

citation for published version (APA)

Johannesma, P. C. (2016). Renal and Pulmonary Aspects of Birt-Hogg-Dubé syndrome.

General rights

Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain

• You may freely distribute the URL identifying the publication in the public portal ?

Take down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

E-mail address:

vuresearchportal.ub@vu.nl

(2)

VRIJE UNIVERSITEIT

Renal and Pulmonary Aspects of

Birt-Hogg-Dubé syndrome.

PhD Thesis

Paul Christiaan Johannesma

Promotores: Prof. dr. P.E. Postmus

Prof. dr. R.J.A. van Moorselaar

Co-promotores: dr. F.H. Menko

dr. J.H.T.M. van Waesberghe

(3)

Title PhD thesis: Renal and Pulmonary Aspects of Birt-Hogg-Dubé syndrome.

Version: Review Committee

Promotores:

Prof. dr. P.E. Postmus

Department of Pulmonary Diseases, VU University Medical Center, Amsterdam, The Netherlands Department of Thoracic Oncology, Clatterbridge Cancer Centre, Liverpool Heart & Chest Hospital, University of Liverpool, Liverpool, United

Prof. dr. R.J.A. van Moorselaar

Department of Urology, VU University Medical Center, Amsterdam, The Netherlands

Co-promotores:

dr. F.H, Menko

Family Cancer Clinic, The Netherlands Cancer Institute, Amsterdam, The Netherlands

dr. J.H.T.M. van Waesberghe

(4)

Review Committee:

Prof. dr. C.J.J. Mulder (Chairman)

Department of Gastroenterology and Hepatology, VU University Medical Center, Amsterdam, The Netherlands

Prof dr. ir. H.A. van Swieten

Department of Cardiothoracic Surgery, Radboud University Medical Center, Nijmegen, The Netherlands

Department of Cardiothoracic Surgery, HagaZiekenhuis, ‘s Gravenhage, The Netherlands

Prof. dr. M.P. Laguna

Department of Urological Oncology, Amsterdam Medical Center, Amsterdam, The Netherlands

dr. L.J. Meijboom

Department of Radiology, VU University Medical Center, Amsterdam, The Netherlands

dr. M. Kets

(5)

Contents

Chapter 0.1.

General introduction and outline of the thesis.

Part one: Pulmonary manifestations.

Chapter 1.1

The pathogenesis of pneumothorax in Birt-Hogg-Dubé syndrome: a hypothesis.

Respirology. 2014 Nov;19(8):1248-50.

Chapter 1.2

Presence of pulmonary cysts in BHD patients with and without a pneumothorax; a retrospective analysis of 61 patients.

(Submitted).

Chapter 1.3

Radiological features of primary spontaneous pneumothorax patients with or without a mutation in

FLCN. (Submitted).

Chapter 1.4

How reliable are clinical criteria in distinguishing between Birt-Hogg-Dubé syndrome and smoking as a cause for pneumothorax?

Histopathology 2014;64(7)1045-6

Chapter 1.5

Risk of spontaneous pneumothorax due to air travel and diving in patients with Birt-Hogg-Dubé syndrome.

(6)

Chapter 1.6

Prevalence of Birt-Hogg-Dubé syndrome in patients with apparently primary spontaneous pneumothorax.

Eur Respir J. 2015;45(4):1191-4.

Chapter 1.7

International guidelines for pneumothorax are not adequate for treatment of spontaneous pneumothorax in patients with Birt-Hogg-Dubé syndrome.

(Submitted)

Part two: Renal manifestations.

Chapter 2.1

Renal cancer and pneumothorax risk in Birt-Hogg-Dubé syndrome; an analysis of 115 FLCN mutation carriers from 35 BHD families.

Br J Cancer. 2011;105(12):1912-9.

Chapter 2.2

Are lung cysts in renal cell cancer (RCC) patients an indication for FLCN mutation analysis?

Fam Cancer. 2016;15(2):297-300

Chapter 2.3

Renal imaging in 199 Dutch patients with Birt-Hogg-Dubé syndrome: Screening, compliance and outcome.

(Submitted)

Part three: Relevant case reports and case series.

Chapter 3.1

In-flight pneumothorax: diagnosis may be missed because of symptom delay.

Am J Respir Crit Care Med. 2014;190(6):704-5.

Chapter 3.2

Spontaneous pneumothorax as indicator for Birt-Hogg-Dubé syndrome in paediatric patients.

(7)

Chapter 3.3

Lung cysts as indicator for Birt-Hogg-Dubé syndrome.

Lung. 2014;192(1):215-6.

Chapter 3.4

Spontaneous pneumothorax as the first manifestation of a hereditary condition with an increased renal cancer risk.

Ned Tijdschr Geneeskd. 2009;153:A581.

Chapter 3.5

Facial fibrofolliculomas as indicator for renal cell cancer.

Jpn J Clin Oncol. 2014;44(6):609-10.

Chapter 3.6

Bilateral renal tumour as indicator for Birt-Hogg-Dubé syndrome.

Case Rep Med. 2014;2014:618675.

Chapter 3.7

A de novo FLCN mutation in a patient with spontaneous pneumothorax and renal cancer; a clinical and molecular evaluation.

Fam Cancer. 2013;12(3):373-9.

Chapter 4.1

Summary of the thesis.

Chapter 5.1

Referenties

GERELATEERDE DOCUMENTEN

1 VU University Medical Center, Department of Medical Microbiology and Infection Control, Amsterdam, 2 VU University Medical Center, Laboratory of Immunogenetics,

Department of Midwifery Science, AVAG and the EMGO Institute for Health and Care Research, VU University Medical Centre, Amsterdam, the Netherlands. Faculty of Health

The work in this thesis was performed at the Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands; Department of Pathology, Landspitali

van Kooyk (Department of Molecular Cell Biology and Immunology, VU University medical center, Amsterdam, The

Department of Clinical Chemistry 1 , VU Medical Center, Amsterdam; Department of Laboratory Medicine 2 , University Medical Center Groningen 2 ; Medial Diagnostic Centers 3

Wouter H Gerritsen, Department of Pathology, Neuroscience Campus Amsterdam, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands Elise S van

During her interview at the department of radiation oncology of the VU University Medical Center, she was offered the opportunity to start with performing research at this

Emmanuelle Leteurtre, Department of Pathology, CHRU Lille, Lille, France Nienke Loosekoot, Department of Medical Oncology, Cancer Center Amsterdam, VU Medisch Centrum, Amsterdam,